Amivantamab, the first epidermal growth factor receptor and mesenchymal–epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia
Cancel-Artau, Karina J., Marrero-Pérez, Angélica C., Michelén-Gómez, Eduardo A., Sánchez-Flores, Xavier
Published in JAAD Case Reports (01.03.2024)
Published in JAAD Case Reports (01.03.2024)
Get full text
Journal Article
Amivantamab, the first epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia
Cancel-Artau, Karina J, Marrero-Pérez, Angélica C, Michelén-Gómez, Eduardo A, Sánchez-Flores, Xavier
Published in JAAD case reports (01.03.2024)
Published in JAAD case reports (01.03.2024)
Get full text
Report